CONDITIONS FOR RIKSBANK AUCTIONS GOVERNMENT BONDS
| Bid procedure, 2025-03-07 | |
| Bonds | SWEDISH GOVERNMENT: 1062. SE0013935319. 2031-05-12 SWEDISH GOVERNMENT: 1056, SE0004517290, 2032-06-01 SWEDISH GOVERNMENT: 1053, SE0002829192, 2039-03-30 |
| Bid date | 2025-03-07 |
| Bid times | 09.00-10.00 (CET/CEST) on the Bid date |
| Offered volume (corresponding nominal amount) | 1062: 1000 million SEK +/-1000 million SEK 1056: 1000 million SEK +/-1000 million SEK 1053: 1000 million SEK +/-1000 million SEK |
| Highest permitted bid volume (corresponding nominal amount) | 1062: 1000 million SEK per bid 1056: 1000 million SEK per bid 1053: 1000 million SEK per bid |
| Lowest permitted bid volume (corresponding nominal amount) | SEK 10 million per bid |
| Expected allocation time | Not later than 10.15 (CET/CEST) on the Bid date |
| Delivery and payment date | 2025-03-11 |
| Settlement amount | To be paid to the Riksbank's account in Euroclear Sweden AB's securities settlement system SWIFT: VPCSSESSXXX Account: 1 4948 6383 CTM BIC: RIKSSESS ALERT acronym: RIKSBANK |
Stockholm, 2025-02-28
This is a translation of the special terms and conditions published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be retrieved atĀ www.riksbank.se.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Brandon Capital Announces Agreement for Novartis to Acquire Portfolio Company Myricx Bio to Advance New Class of Cancer Therapeutics
- Sofinnova Partners Announces Myricx Bio Agrees to Be Acquired by Novartis
- REPRONOVO ANNOUNCES FIRST PARTICIPANT DOSED IN EU PHASE 2 TRIAL OF RPN-002 FOR EMBRYO IMPLANTATION
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share